These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8842703)

  • 1. Ganglioside GM3 inhibition of EGF receptor mediated signal transduction.
    Rebbaa A; Hurh J; Yamamoto H; Kersey DS; Bremer EG
    Glycobiology; 1996 Jun; 6(4):399-406. PubMed ID: 8842703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 and lyso-GM3 in tyrosine phosphorylation of the epidermal growth factor receptor.
    Hanai N; Nores GA; MacLeod C; Torres-Mendez CR; Hakomori S
    J Biol Chem; 1988 Aug; 263(22):10915-21. PubMed ID: 2839511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gangliosides GM3 and De-N-acetyl GM3 on epidermal growth factor receptor kinase activity and cell growth.
    Song WX; Vacca MF; Welti R; Rintoul DA
    J Biol Chem; 1991 Jun; 266(16):10174-81. PubMed ID: 1645342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s).
    Suarez Pestana E; Greiser U; Sánchez B; Fernández LE; Lage A; Perez R; Böhmer FD
    Br J Cancer; 1997; 75(2):213-20. PubMed ID: 9010029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of EGF-mediated receptor activity and cell proliferation by HK1-ceramide, a stable analog of the ganglioside GM3-lactone.
    Alves F; Borchers U; Keim H; Fortte R; Olschimke J; Vogel WF; Halfter H; Tietze LF
    Glycobiology; 2002 Aug; 12(8):517-22. PubMed ID: 12145192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptor.
    Bremer EG; Schlessinger J; Hakomori S
    J Biol Chem; 1986 Feb; 261(5):2434-40. PubMed ID: 2418024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and characterization of N-parinaroyl analogs of ganglioside GM3 and de-N-acetyl GM3. Interactions with the EGF receptor kinase.
    Song W; Welti R; Hafner-Strauss S; Rintoul DA
    Biochemistry; 1993 Aug; 32(33):8602-7. PubMed ID: 8395211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside GM3 blocks the activation of epidermal growth factor receptor induced by integrin at specific tyrosine sites.
    Wang XQ; Sun P; Paller AS
    J Biol Chem; 2003 Dec; 278(49):48770-8. PubMed ID: 14512423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of lipid mimetics of GM3 and lyso-GM3 dimer on EGF receptor tyrosine kinase and EGF-induced signal transduction.
    Haga Y; Hatanaka K; Hakomori SI
    Biochim Biophys Acta; 2008 Mar; 1780(3):393-404. PubMed ID: 18036568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction.
    Zhou Q; Hakomori S; Kitamura K; Igarashi Y
    J Biol Chem; 1994 Jan; 269(3):1959-65. PubMed ID: 7507488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of EGF receptor activity by changes in the GM3 content in a human epidermoid carcinoma cell line, A431.
    Meuillet EJ; Mania-Farnell B; George D; Inokuchi JI; Bremer EG
    Exp Cell Res; 2000 Apr; 256(1):74-82. PubMed ID: 10739654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganglioside induces caveolin-1 redistribution and interaction with the epidermal growth factor receptor.
    Wang XQ; Sun P; Paller AS
    J Biol Chem; 2002 Dec; 277(49):47028-34. PubMed ID: 12354760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppresion] of activation.
    Wang XQ; Sun P; O'Gorman M; Tai T; Paller AS
    Glycobiology; 2001 Jul; 11(7):515-22. PubMed ID: 11447130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth.
    Hanai N; Dohi T; Nores GA; Hakomori S
    J Biol Chem; 1988 May; 263(13):6296-301. PubMed ID: 2834372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomide.
    Mattar T; Kochhar K; Bartlett R; Bremer EG; Finnegan A
    FEBS Lett; 1993 Nov; 334(2):161-4. PubMed ID: 8224241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified ganglioside as a possible modulator of transmembrane signaling mechanism through growth factor receptors: a preliminary note.
    Hanai N; Nores G; Torres-Méndez CR; Hakomori S
    Biochem Biophys Res Commun; 1987 Aug; 147(1):127-34. PubMed ID: 3498483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
    Li Y; Huang X; Zhang J; Li Y; Ma K
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganglioside GM3 promotes carcinoma cell proliferation via urokinase plasminogen activator-induced extracellular signal-regulated kinase-independent p70S6 kinase signaling.
    Wang XQ; Sun P; Go L; Koti V; Fliman M; Paller AS
    J Invest Dermatol; 2006 Dec; 126(12):2687-96. PubMed ID: 16826166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor.
    Yoon SJ; Nakayama K; Hikita T; Handa K; Hakomori SI
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):18987-91. PubMed ID: 17142315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GM3 content modulates the EGF-activated p185c-neu levels, but not those of the constitutively activated oncoprotein p185neu.
    Sottocornola E; Berra B; Colombo I
    Biochim Biophys Acta; 2003 Dec; 1635(2-3):55-66. PubMed ID: 14729068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.